• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/224

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

224 Cards in this Set

  • Front
  • Back
1. What is valvular stenosis vs. valvular insufficiency?
Stenosis is the failure of a valve to open completely, thereby impeding forward flow.

Insufficiency, in contrast, results from failure of a valve to close completely, thereby allowing reversed flow.

These abnormalities can be either pure, when only stenosis or regurgitation is present, or mixed, when both stenosis and regurgitation coexist in the same valve, but one of these defects usually predominates.
2. What are the two things that can cause functional regurgitation?
Functional regurgitation results when a valve becomes incompetent owing to either:
1. Dilation of the ventricle, which causes the right or left ventricular papillary muscles to be pulled down and outward, thereby preventing coaptation of otherwise intact mitral or tricuspid leaflets during systole
2. Dilation of the aortic or pulmonary artery, pulling the valve commissures apart and preventing full closure of the aortic or pulmonary valve cusps.
3. What are the most important clinical consequences of valvular dysfunction?
Most important are the myocardial hypertrophy and the pulmonary and systemic changes.

Moreover, a patch of endocardial thickening often occurs at the point where a jet lesion impinges, such as the focal endocardial fibrosis in the left atrium secondary to a regurgitant jet of mitral insufficiency.
4. What are the most frequent causes of valvular abnormalities?
Most frequent are acquired stenoses of the aortic and mitral valves, which account for approx 2/3rds of all disease.
5. What causes valvular stenosis?
*Valvular stenosis is almost always due to a primary cuspal abnormality and is virtually always a chronic process.
6. What causes valvular insufficiency?
Valvular insufficiency on the other hand may result from either intrinsic disease of the valve cusps or damage to or distortion of the supporting structures (e.g., the aorta, mitral annulus, tendinous cords, papillary muscles, ventricular free wall) without primary changes in the cusps.

It may appear acutely, as w/rupture of cords, or chronically with leaflet scarring and retraction.
7. What are the most freq causes of aortic insufficiency?
Dilation of the ascending aorta, related to hypertension and aging
8. What are the most freq causes of aortic stenosis?
Calcification of anatomically normal and congenitally bicuspid aortic valves
9. What are the most freq causes of mitral insufficiency?
Myxomatous degeneration (mitral valve prolapse)
10. What are the most freq causes of mitral stenosis?
Postinflammatory scarring (rheumatic heart disease)
11. Where in the heart valves are they subject to repetitive mechanical stresses?
At the hinge points at the cusps and leaflets.

This is b/c each are subject to
1. 40 million or more cardiac cycles per year
2. Substantial tissue deformations at each cycles
3. Transvavlvular pressure gradients in the closed phase of approximately 120 mm for the mitral and 20 mm for the aortic valve.
12. What is a consequence of these repetitive mechanical stresses?
It is therefore not surprising that these normally delicate structures suffer cumulative damage complicated by formation of calcific deposits (composed of calcium phosphate material), which may lead to clinically important disease.

*The most freq calcific valvular disease are calcific aortic stenosis, calcification of a congenitally bicuspid aortic valve, and mitral annular calcification.
13. What is calcific aortic stenosis?
Calcific aortic stenosis is the most common of all valvular abnormalities.

It is usually the consequence of calcification owing to progressive and advanced age-associated "wear and tear" of either previously anatomically normal aortic valves or congenitally bicuspid valves (which approx 1% of the population is born).
14. When does aortic stenosis come to clinical attention?
Aortic stenosis comes to clinical attention primarily in the 6th to 7th decades of life w/congenitally bicuspid valves but not until the 8th and 9th decades with previously normal valves; hence the term senile calcific aortic stenosis is used to describe the latter condition.
15. What is the morphologic hallmark of non-rheumatic, calcific aortic stenosis?
The morphologic hallmark is heaped-up calcified masses w/in the aortic cusps that ultimately protrude thru the outflow surfaces into the sinuses of Valsalva, preventing the opening of the cusps.
16. What is the morphology of calcific aortic stenosis?
The calcific deposits distort the cuspal architecture, primarily at the bases. The calcific process begins int the valvular fibrosa, at the points of maximal cusp flexion (the margins of attachment), and the microscopic layered architecture is largely preserved.

In aortic stenosis, the functional valve area is decreased sufficiently to cause measurable obstruction to outflow; this subjects the left ventricular myocardium to progressively increasing pressure overload.
17. What is aortic valve sclerosis?
An earlier, hemodynamically inconsequential stage of the calcification process is called aortic valve sclerosis.
18. What do the valves look like in calcific aortic stenosis?
In contrast to rheumatic stenosis, commisural fusion is not a usual feature of degenerative aortic stenosis.

By the time valves w/aortic stenosis are seen at surgical resection or postmortem exam, however, the cusps may be secondarily fibrosed and thickened.

The mitral valve is generally normal in pts with calcific aortic stenosis, although some pts may have direct extension of aortic valve calcific deposits onto the mitral anterior leaflet or independent calcification of the mitral annulus.
19. What are the clinical features of calcific aortic stenosis (superimposed on a previously normal or biscuspid aortic valve)?
The failure of compensatory hypertrophy mechanisms is heralded by angina (reduced perfusion in hypertrophied myocardium), syncope (and increased risk of sudden death), or CHF.

With onset of such symptoms, and if left untreated, there is a 50% risk of death w/in 2-5 years; urgent surgical valve replacement is clearly indicated.

In contrast, most asymptomatic patients have an excellent prognosis.
20. What is calcific stenosis of congenitally bicuspid aortic valve?
In a congenitally bicuspid aortic valve, there are only two functional cusps.

The cusps are usually of unequal size, with the larger cusp having a midline raphe, resulting from incomplete separation during development; less frequently the cusps are of the same size and the raphe is absent.
21. What is the importance of the raphe?
The raphe that represents the incomplete commissure is frequently a major site of calcific deposits.
22. What is the prevalence of calcific stenosis of a congenitally biscuspid aortic valve?
Occurring w/an estimated freq of approximately 1.4% of live births, bicuspid aortic valves are generally neither stenotic nor symptomatic at birth or throughout early life.

However, they are predisposed to progressive degenerative calcification.
23. What are the clinical features of calcific stenosis of a congenitally biscuspid aortic valve?
Once stenosis is present, the clinical course is similar to that described for calcific aortic stenosis.

The mitral valve is normal. Bicuspid aortic valves may also become incompetent as a result of aortic dilation, cusp prolapse, or infective endocarditis.
24. What is mitral annular calcification?
Degenerative calcific deposits can develop in the fibrous ring (annulus) of the mitral valve, visualized on gross inspection as irregular, stony hard, and occasionally ulcerated nodules (2-5 mm in thickness) that lie behind the leaflets.

This process gernally does not affect valvular function. It occurs most commonly in women over age 60 and individuals with myxomatous mitral valve, or elevated left ventricular pressure.
25. What are four important points to remember about mitral annular calcification?
1. Regurgitation can occur from inadequate systolic contraction of the mitral valve ring
2. Stenosis can occur b/c leafelets are unable to open over bulky deposits
3. Nodular calcific deposits can impinge on conduction pathways, causing arrhythmias
4. Rarely, these deposits become a focus for infective endocarditis
26. What is myxomatous degeneration of the mitral valve?
AKA MVP. In this valvular abnormality, one or both mitral leaflets are "floppy" and prolapse, or balloon back into the left atrium during systole.

It is estimated to affect 3% of more of adults in the US, most often young women. It is one of the most common forms of valvular heart disease.
27. What is the morphology of myxomatous degeneration?
The characteristic anatomic change in myxomatous degeneration is intercordal ballooning (hooding) of the mitral leaflets or portions thereof. The affected leaflets are often enlarged, redundant, thick, and rubbery. Frequently involved, the tendinous cords are elongated, thinned, and occasionally ruptures.

Annular dilation is characteristic.
28. What are the histologic characteristics of myxomatous degeneration?
Histologically, the essential change is attenuation of the fibrosa layer of the valve, on which the structural integrity of the leaflet depends, accompanied by focally marked thickening of the spongiosa layer w/deposition of mucoid (myxomatous) material. The collagenous structure of the cords is attenuated.
29. What are five secondary changes that reflect the stresses and injury incident to the billowing leaflets in MVP?
1. Fibrous thickening of the valve leaflets, particularly where they rub against each other
2. Linear fibrous thickening of the left ventricular endocardial surface where abnormally long cords snap against it
3. Thickening of the mural endocardium of the left ventricle or atrium as a consequence of friction induced injury induced by the prolapsing leaflets
4. Thrombi on the atrial surfaces of the leaflets, particularly in the recesses behind the ballooned cusps, and on the atrial walls these thrombi contact
5. Focal calcifications at the base of the posterior mitral leaflet
30. What is the pathogenesis of MVP?

What other conditions does MVP commonly co-occur in?
The basis for the changes within the valve leaflets are associated structures is unknown. Favored is the proposition that there is an underlying developmental defect of connective tissue, possibly systemic.

In keeping with this, myxomatous degeneration of the mitral valve is a common feature of Marfan syndrome (caused by mutations in the gene encoding fibrillin-1) and occasionally occurs in other hereditary disorders of connective tissues.
31. What are the clinical features of MVP?
Mitral valve prolapse is generally asymptomatic and discovered only as a midsystolic click on auscultation.

It can be associated with atypical chest pain, dyspnea, fatigue, or psychiatric manifestations (e.g., depression, anxiety).

Importantly there is an increased risk of:
1. Infective endocarditis
2. Gradual mitral valvular insufficiency to produce CHF
3. Arrhythmias
4. Sudden death
32. What is rheumatic fever and rheumatic heart disease?
Rheumatic fever is an acute, immunologically mediated, multisystem inflammatory disease that occurs a few weeks following an episode of group A streptococcal pharyngitis.

Acute rheumatic carditis during the active phase of RF may progress to chronic rheumatic heart disease.
33. What are the most important consequences of RF?
Chronic valvular deformities, characterized principally by deforming fibrotic valvular disease (particularly mitral stenosis), which produces permanent dysfunction and severe, sometimes, fatal, cardiac problems decades later.
34. What are the key pathologic features of acute RF?

1/2
During acute RF, focal inflammatory lesions are found in various tissues. They are most distinctive within the heart, where they are called Aschoff bodies. They consist of foci of swollen esoinophilic collagen surrounded by lymphocytes (primarily T cells), occasional plasma cells, and plump macrophages called Anitschkow cells (pathognomonic for RF). These distinctive cells have abundant cytoplasm and central round-to-ovoid nuclei in which the chromatin is disposed in a central, slender wavy ribbon (caterpillar cells).
35. What are the key pathologic features of acute RF?

2/2
During acute RF, diffuse inflammation and Aschoff bodies may be found in any of the three layers of the heart - pericardium, myocardium, or endocardium.

In the pericardium, the inflammation is accompanied by a fibrinous or serofibrinous pericardial exudate, described as a "bread-and-butter" pericarditis, which generally resolves w/o sequelae.

The myocardial involvement - myocarditis - takes the form of scattered Aschoff bodies w/in the interstitial connective tissue, often perivascular.
36. What are verrucae?
Concomitant involvement of the endocardium and the left-sided valves by inflammatory foci typically results in fibrinoid necrosis w/in the cusps or along the tendinous cords on which sit small vegetations - verrucae - along the lines of closure.

These irregular, warty projections probably arise from the precipitation of fibrin at sites of erosion, related to underlying inflammation and collagen degeneration, and cause little disturbance in cardiac function.
37. What are MacCullum plaques?
Subendocardial lesions, perhaps exacerbated by regurgitant gets, may induce irregular thickenings called MacCallum plaques, usually in the left atrium.
38. What is the morphology of chronic RHD?

1/2
Chronic RHD is characterized by organization of acute inflammation and subsequent fibrosis. In particular, the valvular leaflets become thickened and retracted, causing permanent deformity.

***The cardinal anatomic changes of the mitral (or tricuspid) valve are leaflet thickening, commissural fusion and shortening, and thickening and fusion of tendinous cords.***
39. What is the morphology of chronic RHD?

2/2
In chronic disease, the mitral valve is virtually always abnormal, but involvement of another valve, such as the aortic, may be the most clinically important in some cases.

Microscopically there is diffuse fibrosis and often neovascularization that obliterate the originally layered and avascular leaflet architecture.

Aschoff bodies are replaced by fibrous cars so that diagnostic forms of these lesions are rarely seen in surgical specimens or autopsy tissue.
40. What is the most frequent cause of mitral stenosis?
RHD is overwhelmingly the most frequent cause of mitral stenosis (99% of cases)

Fibrous bridging across the valvular commissures and calcification create "fish mouth" or "buttonhole" stenoses. With tight mitral stenosis, the left atrium progressively dilates and may harbor mural thrombus either in the appendage or along the wall.
41. What is the pathogenesis of acute rheumatic fever and RHD?
It is strongly suspected that acute rheumatic fever is a hypersensitivity reaction induced by group A streptococci.

It is thought that antibodies directed against the M proteins of certain strains of streptococci cross-react w/glycoprotein antigens in the heart, joints, and other tissues. The onset of symptoms 2-3 weeks after infection and the absence of streptococci from the lesions support the concept that RF results from an immune response against the offending bacteria.

*The chronic sequelae result from progressive fibrosis due to both healing of the acute inflammatory lesions and the turbulence induced by ongoing valvular deformities.
42. What are the five major clinical manifestations of rheumatic fever?
1. Migratory polyarthritis of the large joints
2. Carditis
3. Subcutaenous nodules
4. Erythema marginatum of the skin
5. Sydenham chorea, a neurologic disorder w/involuntary purposeless, rapid movements.
43. How is the Dx of rheumatic fever made?
The Dx is established by the so-called Jones criteria: evidence of a preceding group A streptococcal infection, w/the presence of two of the major manifestations listed above or one major and two minor manifestations (nonspecific signs and symptoms that include fever, arthralgia, or elevated blood levels of acute phase reactants).
44. What are the clinical features of acute rheumatic fever?
Acute RF typically occurs 10 days to 6 weeks after an episode of pharyngitis caused by group A streptococci in about 3% of pts. Acute RF appears most often in children between ages 5 and 15, but about 20% of first attacks occur in middle to later life.

*The predominant clinical manifestations are those of arthritis and carditis (arthritis is far more common in adults than in children).
45. What are the clinical features related to acute carditis?
Clinical features related to acute carditis include pericardial friction rubs, weak heart sounds, tachycardia, and arrhythmias.

The myocarditis may cause cardiac dilation that may evolve to functional mitral valve insufficiency or even heart failure.
46. What are the complications that can result from acute rheumatic fever?
After an initial attack, there is increased vulnerability to reactivation of the disease with subsequent pharyngeal infections, and the same manifestations are likely to appear with each recurrent attack.

Carditis is likely to worsen w/each recurrence, and damage is cumulative. Other hazards include embolization from mural thrombi, primarily w/in the atria or their appendages, and infective endocarditis superimposed on deformed valves.
47. When does chronic rheumatic carditis occur?

What other complications can result from RF?
Chronic rheumatic carditis usually does not cause clinical manifestations for years or even decades after the initial episode of RF. The signs and symptoms of valvular disease depend on which cardiac valves are vinovled.

In addition to various cardiac murmurs, cardiac hypertrophy and dilation, and heart failure, pts w/chronic rheumatic heart disease may suffer from arrhythmias (particularly atrial fibrillation in the setting of mitral stenosis).
48. What is infective endocarditis?
Infective endocarditis, one of the most serious of all infections, is characterized by colonization or invasion of the heart valves or the mural endocardium by a microbe, leading to the formation of bulky, friable vegetations composed of thrombic debris and organisms, often associated w/destruction of the underlying cardiac tissues.

The aorta, aneurysmal sacs, other blood vessels, and prosthetic devices can also become infected.

*Most cases are bacterial (bacterial endocarditis).
49. What is acute endocarditis?

What is subacute endocarditis?
Acute endocarditis describes a destructive, tumultuous infection, frequently of a previously normal heart valve, w/a highly virulent organism, that leads to death within days to weeks of more than 50% of pts despite antibiotics and surgery.

In such cases, the disease may appear insidiously and, even untreated, pursue a protracted course of weeks to months (subacute endocarditis).
50. What are the different clinical effects of the highly virulent organisms in acute endocarditis vs. the lower virulence organisms of subacute disease?
The highly virulent organisms of acute endocarditis tend to produce necrotizing, ulcerative, invasive valvular infections that are difficult to cure by antibiotics and usually require surgery.

In contrast, the lower virulence organisms of subacute disease are less destructive than those of acute endocarditis, and the vegetations often show evidence of healing.
51. What causes acute infective endocarditis?
Acute infective endocarditis is caused by highly virulent organisms (e.g., Staphylococcus aureus), often seeding a previously normal valve to produce necrotizing, ulcerative and invasive infections.

Clinically, there is a rapidly developing fever w/rigors, malaise, and weakness. Larger vegetations can cause embolic complications; splenomegaly is common.
52. What causes subacute infective endocarditis?
Subacute infective endocarditis is typically caused by moderate to low virulence organisms (frequently Streptococcus viridans) seeding an abnormal or previously injured valve.

There is less valvular destruction than acute infective endocarditis.

This pattern occurs insidiously w/nonspecific malaise, low-grade fever, weight loss, and a flu-like syndrome. Vegetations tend to be so small that embolic complications occur less frequently.
53. What is the pathogenesis of infective endocarditis?
Blood-borne organisms, usually bacteria, are prerequisites for infective endocarditis. Seeding of the blood with microbes is the foremost factor.

They can come from infections elsewhere in the body, IV drug abuse (S. aureus!), dental or surgical procedures, or otherwise trivial injury to gut, urinary tract, oropharynx, or skin.

Contributory conditions include neutropenia and immunosuppression.
54. What is the morphology of infective endocarditis?
In both the acute and subacute forms of the disease, friable, bulky, and potentially destructive vegetations containing fibrin, inflammatory cells, and bacteria or other organissm are present on the heart valves.

*The aortic and mitral valves are the most common sites of infection, although the valves of the right heart may also be inovlved, particularly in IV drug abusers.

The vegetations may be single or multiple and may involve more than one valve.
55. What is a ring abscess?

What about the vegetations in fungal endocarditis?
Vegetations sometimes erode into the underlying myocardium to produce an abscess cavity called a ring abscess, one of the several important complications.

*Note: fungal endocarditis tends to cause larger vegetations than does bacterial infection.
56. What is the morphology subacute endocarditis?
The vegetations of subacute endocarditis are associated w/less valvular destruction than those of acute endocarditis, although the distinction between the two forms may be difficult.

Microscopically, the vegetations of typical subacute IE often have granulation tissue at their bases (suggesting chronicity).

With the passage of time, fibrosis, calcification, and a chronic inflammatory infiltrate may develop.
57. What are three important things to remember regarding the clinical features of infective endocarditis?
1. Direct injury to valves *causing insufficiency with CHF) or myocardium and aorta (causing ring abscess or perforation)
2. Emboli from vegetations to spleen, kidneys, heart, and brain with infarction or metastatic infection (septic infarct)
3. Renal injury, including embolic infarction or infection and antigen-antibody complex-mediated glomerulonephritis with nephrotic syndrome, renal failure, or both.
58. What is the Duke criteria?
The Duke criteria provide a standardized assessment of pts with suspected IE that integrates factors predisposing pts to the development of IE, blood culture evidence of infection, ECK findings, and clinical and laboratory information in assessing pts with potential IE.

Dx by these guidelines often requires either pathologic or clinical criteria. If clinical criteria are used, 2 major, 1 major, +3 minor, or 5 minor criteria are required for Dx.
59. What are the minor features included in the Dx of infective endocarditis?
They include petechiae, red, linear, or flame-shaped streakes in the nail bed of the digits (splinter or subungual hemorrhages), erythematous or hemorrhagic nontender lesions on the palms or soles (Janeway lesions), subcutaneous nodules in the pulp of the digits (Osler nodes)

Also included are retinal hemorrhages (Roth spots) in the eyes owing to the shortened clinical course of the disease as a result of antibiotic therapy.
60. What is nonbacterial thrombotic endocarditis (NBTE)?
NBTE is characterized by the deposition of small masses of fibrin, platelets, and other blood components on the leaflets of the cardiac valves.

***In contrast to the vegetations of IE, the valvular lesions of NBTE are sterile and do not contain microrganisms.***
61. When does NBTE occur?
NBTE is often encountered in debilitated patients, such as those w/cancer or sepsis.

Although the local effect on the valves is usually unimportant, NBTE may achieve clinical significance by producing emboli and resultant infarcts int eh brain, heart, or elsewhere.
62. What is the morphology of NBTE?
In contrast to IE, the vegetations of NBTE are sterile, nondestructive, and small (1-5 mm), and occur singly or multiply along the line of closure of the leaflets or cusps.

Histologically, they are composed of bland thrombus w/o accompanying inflammatory reaction or induced valve damage. Should the pt survive the underlying disease, organization may occur, leaving delicate strands of fibrous tissue.
63. What is the pathogenesis of NBTE?
NBTE frequently occurs concomitantly w/venous thromboses or pulmonary embolism, suggesting a common origin in a hypercoagulable state with systemic activation of blood coagulation such as disseminated intravascular coagulation.

This may be unrelated to some underlying disease, such as cancer, and in particular, mucinous adenocarcinomas of the pancreas.

The striking association with mucinous adenocarcinomas may relate to the procogulant effect of circulating mucin, and thus NBTE can be a part of the Trousseau syndrome.
64. In what other conditions does NBTE occur?
NBTE is also seen occasionally in association w/nonmucin-producing malignancy, such as acute promyelocytic leukemia, and in other debilitating diseases or conditions promoting hypercoagulability.

Endocardial trauma, as from an indwelling catheter, is also a well-recognized predisposing condition, and one freq notes right-sided valvular and endocardial thrombotic lesions along the track of a Swan-Ganz pulmonary artery catheter.
65. What is endocarditis of SLE (Libman-Sacks disease)?
In SLE, mitral and tricuspid valvulitis w/small, sterile vegetations, called Libman-Sacks endocarditis is occasionally encountered.
66. What is the morphology of endocarditis of SLE (Libman-Sacks disease)?
The lesions are small single or multiple, sterile, granular pink vegetations ranging from 1-4 mm in diameter. The lesions may be located on the undersurfaces of the AV valves, on the valvular endocardium, on the cords, or on the mural endocardium of atria or ventricles.

*Histologically, the verrucae consist of a finely granular, fibrinous eosinophilic material that may contain hematoxylin bodies (the tissue equivalent of the lupus erythematosus cell of the blood and bone marrow).

An intense valvulitis may be present, characterized by fibrinoid necrosis of the valve substance that is often contiguous w/the vegetation.
67. What is the significance of antiphospholipid syndrome?
Thrombotic heart valve lesions w/sterile vegetations or rarely fibrous thickening commonly occur w/the antiphospholipid syndrome.

Circulating antiphospholipid antibodies are also commonly associated w/venous or arterial thrombosis, recurrent pregnancy loss, or thrombocytopenia. The mitral valve is more freq involved than the aortic; regurgitation is the usual functional abnormality.
68. What is carcinoid heart disease?
Carcinoid heart disease is the cardiac manifestation of the systemic syndrome caused by carcinoid tumors. It involves the endocardium and valves of the right heart.

Cardiac lesions are present in one half of pts with the carcinoid syndrome which is characterized by episodic flushing of the skin, cramps, nausea, vomiting, and diarrhea.
69. What is the morphology of carcinoid heart disease?
The cardiovascular lesions associated w/the carcinoid syndrome are distinctive, consisting of fibrous intimal thickenings on the inside surfaces of the cardiac chambers and valvular leaflets.

The are located mainly in the right ventricle, tricuspid, and pulmonic valves, and occasionally in the major blood vessels. The endocardial plaquelike thickening are composed predominantly of smooth muscle cells and sparse collagen fibers embedded in an acid mucopolysaccharide-rich matrix material. Elastic fibers are not present.
70. The clinical and pathologic findings of carcinoid heart disease relate to...?
Relate to the elaboration by carcinoid tumors of a variety of bioactive products, such as serotonin, kallikrein, bradykinin, histamine, prostaglandins, and tachykinins.

Plasma levels of serotonin and urinary excretion of the serotonin metabolite 5-hydroxyindoleacetic acid correlate with the severity of the right heart lesion.
71. Why are the cardiac changes in carcinoid heart disease largely right sided?
This is explained by inactivation of both serotonin and bradykinin in the blood during passage thru the lungs by the monoamine oxidase present in the pulmonary vascular endothelium.

*Left sided lesions can occur when blood containing the responsible mediator enters the left heart owing to incomplete inactivation b/c of very high blood levels. Also, the use of fenfluramine and phentermine may affect systemic serotonin metabolism and cause left-sided lesions.
72. What are the two categories of artificial valves?
1. Mechanical prostheses using various types of rigid, mobile occluders composed of nonphsyiologic biomaterials, such as caged balls, tilting disks, or hinged semicircular flaps.

2. Tissue valves, usually bioprostheses consisting of chemically treated animal tissue, especially porcine aortic valve tissue, which has been preserved in a dilute glutaraldehyde solution and subsequently mounted on a prosthetic frame. Tissue valves are flexible and function somewhat like natural semilunar valves.
73. What are five main causes of failure for cardiac valve prostheses?
1. Thrombosis/thromboembolism
2. Anticoagulant-related hemorrhage
3. Prosthetic valve endocarditis
4. Structural deterioration (intrinsic)
5. Nonstructural dysfunction

*Approx 60% of substitute valve recipients develop a serious prosthesis-related problem w/in 10 years postoperatively.
74. What are the thromboembolic complications of cardiac valve prostheses?
Thromboembolic complications constituting local obstruction of the prosthesis by thrombus or distant thromboemboli are the major problem w/mechanical valves.

This neccesitates long-term anticoagulation in pts w/these devices. However, hemorrhagic complications such as stroke or GI bleeding may arise secondarily in pts who receive long term anticoagulation.
75. What about infective endocarditis and valve prostheses?
Infective endocarditis is an infrequent but potentially serious complication. Endocarditis is located at the prosthesis-tissue interface, causing a ring abscess, which can eventually lead to a paravalvular regurgitant blood leak. In addition, vegetations may directly inovle bioprosthetic valvular cusps.

The major organisms causing such infections are staph skin contaminants (S. aureus, S. epidermidis), streptococci, and fungi.
76. What about structural deterioration as a problem w/valve prostheses?
Structural deterioration uncommonly causes failure of contemporary mechanical valves.

However, it is a major failure mode of bioprostheses, with calcification and/or tearing causing secondary regurgitation.
77. What does cardiomyopathy mean?

What are the three clinical, functional, and pathologic patterns of cardiomyopathy?
The term cardiomyopathy is used to describe heart disease resulting from a primary abnormality in the myocardium. In many cases, cardiomyopathies are idiopathic.

Three patterns:
1. Dilated cardiomyopathy
2. Hypertrophic cardiomyopathy
3. Restrictive cardiomyopathy
78. Which is the most common form of cardiomyopathy?

Which is the least common?
The dilated form is most common (90% of cases), and the restrictive is the least prevalent.
79. What are endomyocardial biopsies?
They are used in the Dx and management of pts w/myocardial disease and in cardiac transplant recipients.

Endomyocardial biopsy involves inserting a device (bioptome) transvenously into the right side of the heart and snipping a small piece of septal myocardium in its jaws, which is then analyzed by a pathologist.
80. What is dilated cardiomyopathy (DCM)?
DCM is applied to a form of cardiomyopathy characterized by progressive cardiac dilation and contractile (systolic) dysfunction, usually w/concomitant hypertrophy. It is sometimes called congestive cardiomyopathy.

*The left ventricular ejection fraction is < 40%.
81. What is the morphology of DCM?
In DCM, the heart is usually heavy, often weighing 2-3 times normal, and large and flabby, with dilation of all chambers. Nevertheless, b/c of the wall thinning that accompanies dilation, the ventricular thickness may be less than, equal to, or greater than normal.

Mural thrombi are common and may be a source of thromboemboli. There are no primary valvular alterations, and mitral or tricuspid regurgitation, when present, results from left ventricular chamber dilation. The coronary arteries are usually free of significant narrowing, but any coronary artery obstructions present are insufficient to explain the degree of cardiac dysfunction.
82. What are the histologic abnormalities in idiopathic DCM?
The histologic abnormalities in idiopathic DCM also are nonspecific and usually do not reflect a specific etiologic agent.

Moreover, their severity does not necessarily reflect the degree of dysfunction or the pts prognosis.
83. OK then, so what are the histologic characteristics of DCM?
Most muscle cells are hypertrophied with enlarged nuclei, but many are attenuated, stretched, and irregular.

Interstitial and endocardial fibrosis of variable degree is present, and small subendocardial scars may replace individual cells or groups of cells, probably reflecting healing of previous secondary myocyte ischemic necrosis caused by hypertrophy-induced imbalance between perfusion, supply and demand.
84. What are the 9 causes of DCM?
1. Idiopathic
2. Alcohol
3. Peripartum
4. Genetic
5. Myocarditis
6. Hemochromatosis
7. Chronic anemia
8. Doxorubicin toxicity
9. Sarcoidosis
85. How is myocarditis related to DCM?
Viral nucleic acids from coxsackievirus B and other enteroviruses have been detected in the myocardium of some pts, and sequential endomyocardial biopsies have demonstrated progression from myocarditis to DCM in others, suggesting that, in at least some cases, DCM was a consequence of myocarditis.
86. How does alcohol abuse relate to DCM?
Alcohol abuse is also strongly associated with the development of DCM, raising the possibility that ethanol toxicity or a secondary nutritional disturbance may be the cause of the myocardial injury.

Alcohol or its metabolites have a direct toxic effect on the myocardium. Moreover, chronic alcoholism may be associated with thiamine deficiency, introducing an element of beriberi heart disease.
87. What is peripartum cardiomyopathy?
A special form of dilated cardiomyopathy, termed peripartum cardiomyopathy, occurs late in pregnancy or several weeks to months postpartum. The cause of peripartum cardiomyopathy is poorly understood but is probably multifactorial.

Pregnancy-associated hypertension, volume overload, nutritional deficiency, other metabolic derangement, or an as yet poorly characterized immunologic reaction may be involved.
88. How does genetics play a role in the development of DCM?
DCM has a familial occurrence in 25-35% of cases. Autosomal dominant inheritance is most common.

***The known genetic abnormalities largely involve cytoskeletal proteins***, such as dystrophin in X-linked cardiomyopathy (Duchenne and Becker muscular dystrophies).

Others involve mutations of enzymes involved in fatty acid β-oxidation.

**Mitochondrial defects most frequently cause DCM in children.
89. What protease is shown to cleave dystrophin directly?
Myocarditis-associated enteroviral protease 2A has been shown to cleave dystrophin directly, suggesting a mechanism for the development of postmyocarditis DCM.

Disruption of dystrophin is a common finding in end-stage cardiomyopathy, dilated or ischemic. This disruption is reversible, correlating with improvements in some pts. This suggests that damage to the cytoskeleton may provide a final common pathway for contractile dysfunction in heart failure.
90. Besides dystrophin, what other genes are implicated in DCM?
1. α-cardiac actin (which links the sarcomere with dystrophin)
2. Desmin
3. Nuclear lamin proteins (lamin A and C)
91. What are the clinical features of DCM?
Can occur at any age, but it most commonly affects individuals between the ages of 20-50. It presents w/slowly progressive signs and symptoms of CHF such as dyspnea, easy fatigability, and poor exertional capacity, but pts may slip from a compensated to a decompensated functional stage.

In the end stage, pts often have ejection fractions of less than 25% . 50% die within 2 years, and only 25% survive longer than 5 years.

Secondary mitral regurgitation and abnormal cardiac rhythms are common. *Death is usually attributable to progressive cardiac failure or arrhythmia and can occur suddenly.
92. What is arrhythmogenic right ventricular cardiomyopathy (AKA arrhythmogenic right ventricular dysplasia)?
Arrhythmogenic right ventricular cardiomyopathy is a poorly understood condition with a distinct clinical presentation.

It is most commonly associated w/right-sided heart failure and various rhythm disturbances, particularly v-tach. Left sided involvement with left-sided heart failure may also occur. In some cases it gives rise to sudden death.
93. What is the morphology of arrhythmogenic right ventricular cardiomyopathy?
The right ventricular wall is severely thinned due to loss of myocytes, with extensive fatty infiltration and interstitial fibrosis.
94. What is the pathogenesis of arrhythmogenic right ventricular cardiomyopathy?
Most cases have no family history but familial forms do occur.

A gene defect on chromosome 14 is a candidate. Pedigree analyses of large kindreds indicate autosomal dominant inheritance w/variable penetrance.
95. What is Naxos syndrome?

What gene is responsible for Naxos syndrome?
Naxos syndrome appears to be a related disorder that has similar cardiac findings in addition to hyperkeratosis of plantar palmar skin surfces.

The abnormal gene in Naxos disease codes for plakoglobin, also known as γ-catenin, an intracellular protein that links transmembrane adhesion molecules in desmosomes to desmin, the principal intermediate filament protein in cardiac myocytes.
96. What is hypertrophic cardiomyopathy (HCM)?
HCM is AKA by such terms as idiopathic hypertrophic subaortic stenosis and hypertrophic obstructive cardiomyopathy.

It is characterized by myocardial hypertrophy, abnormal diastolic filling and, in about 1/3 of cases, intermittent ventricular outflow obstruction.

*The heart is thick-walled, heavy, and hypercontracting, in striking contrast to the flabby, hypocontracting heart of DCM.
97. Does HCM cause systolic or diastolic dysfunction?
HCM causes primarily diastolic dysfunction; systolic function is usually preserved.
98. What is the morphology of HCM?
*The essential feature of HCM is massive myocardial hypertrophy w/o ventricular dilation.

The classic pattern is disproportionate thickening of the ventricular septum as compared with the free wall of the left ventricle (w/a ratio greater than 1:3), frequently termed asymmetrical septal hypertrophy.

On cross section, the ventricular cavity loses its usual round to ovoid shape and may be compressed into a "banana-like" configuration by bulging of the ventricular septum into the lumen. The hypertrophy is most prominent in the subaortic region.
99. What are the three most important features of the myocardium in HCM?
1. Extensive myocyte hypertrophy to a degree unusual in other conditions, w/transverse myocyte diameters frequently greater than 40 um.

2. Haphazard disarray of bundles of myocytes, individual myocytes, and contractile elements in sarcomeres w/in cells (myofiber disarray).

3. Interstitial and replacement fibrosis.
100. What is the pathogenesis of HCM?
Caused by a mutation in any one of several genes that encode proteins that are part of the sarcomere, the contractile unit of cardiac and skeletal muscle.

Thus, HCM is a genetic disease of force generation within the cardiac myocyte. Most cases are familial and the pattern of transmission is autosomal dominant with variable expression.
101. What genes are involved in HCM?

Which are most common?
1. β-myosin heavy chain
2. Cariac troponinT
3. α-tropomyosin
4. Myosin-binding protein C (MYBPC)

***Mutations in the β-myosin heavy chain gene are most common; MYBPC and troponin T are next. (These three genes account for 70-80% of all cases of HCM).
102. What is the most commonly reported mutation in HCM?
A 403 Arg -> Gln (in β-myosin heavy chain) is the most commonly reported mutation and has been described in multiple families.
103. What is the hypothesis regarding why hypertrophy occurs?
One hypothesis considers cardiac hypertrophy in HCM a compensatory phenomenon owing to impaired contraction of cardiac myocytes, which triggers the release of growth factors that result in intense compensatory hypertrophy (leading to myofiber disarray) and fibroblast proliferation (causing interstitial fibrosis).
104. What are the clinical features of HCM?
The basic physiologic abnormality in HCM is reduced chamber size and poor compliance with reduced stroke volume that results from *impaired diastolic filling of the massively hypertrophied left ventricle*.

In addition, approximately 25% of patients w/HCM have dynamic obstruction to the left ventricular outflow. Auscultation discloses a harsh systolic ejection murmur, caused by ventricular outflow obstruction as the anterior mitral leaflet moves toward the ventricular septum during systole.

Anginal pain is frequent.
105. What are the major clinical problems in HCM?
Atrial fibrillation with mural thrombus formation and possibly embolization, infective endocarditis of the mitral valve, intractable cardiac failure, ventricular arrhythmias, and sudden death.

HCM is one of the most common causes of sudden, otherwise unexplained, death in young athletes.
106. What is restrictive cardiomyopathy?
Restrictive cardiomyopathy is a disorder characterized by a primary decrease in ventricular compliance, resulting in impaired ventricular filling during diastole; the contractile (systolic) function of the left ventricle is usually unaffected.

RCM can be idiopathic or associated with distinct diseases that affect the myocardium, principally radiation fibrosis, amyloidosis, sarcoidosis, metastatic tumor. or products of inborn errors of metabolism.
107. What is the morphology of restrictive cardiomyopathy?
In idiopathic restrictive cardiomyopathy, the ventricles are of approximately normal size or slightly enlarged, the cavities are not dilated, and the myocardium is firm. Biatrial dilation is commonly observed.

Microscopically, there is often only patchy or diffuse interstitial fibrosis, which can vary from minimal to extensive.
108. What is endomyocardial fibrosis?
Endomyocardial fibrosis is principally a disease of children and young adults in Africa and other tropical areas, characterized by fibrosis of the ventricular endocardium and subendocardium that extends from the apex toward, and often involves the tricuspid and mitral valves. The fibrous tissue markedly diminishes the volume and compliance of affected chambers and so induces a restrictive functional defect.

Ventricular mural thrombi sometimes develop, and indeed there is a suggestion that the fibrous tissue results from the organization of mural thrombi.
109. What is Loeffler endomyocarditis?
Loeffler endomyocarditis is also marked by endomyocardial fibrosis, typically w/large mural thrombi similar to those seen in tropic disease, but cases are not restricted to a specific geographic area.

In addition to the cardiac changes, there is often an eosinophilic leukemia, which can result in infiltration of other organs by eosinophils and a rapidly fatal downhill course. The circulating eosinophils are abnormal, and many are degranulated.
110. What is the pathogenesis of Loeffler endomyocarditis?
The release of toxic products of eosinophils, especially major basic protein, is postulated to initiate endocardial damage, with subsequent foci fo endomyocardial necrosis accompanied bya n esoinphilic infiltrate. This is followed by scarring of the necrotic area, layering of the endocardium by thrombus, and finally organization of the thrombus.

Eosinophilic endomyocardial disease has a poor prognosis, but removal of the fibrous/thrombotic layer of tissue (called endomyocardial stripping) is sometimes beneficial.
111. What is endocardial fibroelastosis?
Endocardial fibroelastosis is an uncommon heart disease of obscure etiology characterized by focal or diffuse fibroelastic thickening usually involving the mural left ventricular endocardium.

Most common in the first two years of life, it is often accompanied by some form of congenital cardiac anomaly, aortic valve obstruction in about 1/3 of all cases.

Focal disease may have no functional importance, but diffuse involvement may be responsible for rapid and progressive cardiac decompensation and death.
112. Is the inflammation in myocarditis the response to myocardial injury?
No. *In myocarditis, the inflammatory process is the cause of rather than a response to myocardial injury.
113. What is the pathogenesis of myocarditis?

1/2
In the US, infections and particularly viruses are the most common cause of myocarditis. Coxsackieviruses A and B and other enteroviruses probably account for most of the cases. Other less common agents include CMV, HIV.

Whether the viruses are the direct cause of th emyocardial injury or they initiate an immune response that cross-reacts w/myocardial cells is unclear.
114. What is the pathogenesis of myocarditis?

2/2
Nonviral biologic agents are an important cause of myocarditis, particularly direct cardiac infection caused by the protozoa Trypanosoma cruzi, the agent of Chagas disease.

Trichinosis is the most common helminthic disease w/associated parasitic involvement.

Parasitic diseases, including toxoplasmosis and bacterial infections, including Lyme disease and diphtheria, can also cause myocarditis.
115. What causes the myocardial injury in diphtheritic myocarditis?
Toxins released by Corynebacterium diphtheriae appear to be responsible for the myocardial injury.
116. What about Lyme disease as a cause of myocarditis?
Myocarditis occurs in approx 5% of pts w/Lyme disease (caused by Borrelia burgdorferi).

Lyme carditis manifests primarily as a self-limited conduction system disease.

Nevertheless, a temp pacemaker is required for AV block in approx 30% of pits.
117. What type types of myocarditis occur in pts with AIDS?
1. Inflammation and myocyte damage w/o a clear etiologic agent
2. Myocarditis caused directly by HIV or by an opportunistic pathogen
118. What are the noninfectious causes of myocarditis?
Those related to allergic reactions (hypersensitivity myocarditis), often to a particular drug such as antibiotics, diuretics, and antihypertensive agents.

Myocarditis can also be associated w/systemic diseases of immune origin, such as RF, SLE, and polymyositis.

Cardiac sarcoidosis and rejection of a transplanted heart are also considered forms of myocarditis.
119. What is the morphology of the active phase of myocarditis?

1/2
During the active phase, the heart may appear normal or dilated; some hypertrophy may be present. The lesions may be diffuse or patchy. The ventricular myocardium is typically flabby and often mottled by either pale foci or minute hemorrhagic lesions. Mural thrombi may be present in any chamber.
120. What is the morphology of the active phase of myocarditis?

2/2
***During active disease, myocarditis is most freq characterized by an interstitial inflammatory infiltrate and focal necrosis of myocytes adjacent to the inflammatory cells.***

Myocarditis in which the infiltrate is mononuclear and predominantly lymphocytic is most common.

Endomyocardial biopsies can be negative b/c inflammatory involvement may be focal or patchy.
121. What is the morphology of hypersensitivity myocarditis?
Hypersensitivity myocarditis has interstitial infiltrates, principally perivascular, composed of lymphocytes, macrophages, and a high proportion of eosinophils.
122. What is giant cell myocarditis?

What is the morphology of this variant?
A morphologically distinctive form of myocarditis of uncertain cause is called giant cell myocarditis.

It is characterized by a widespread inflammatory cellular infiltrate containing multinucleate giant cells interspersed with lymphocytes, eosinophils, plasma cells, and macrophages and having at least focal but frequently extensive necrosis. The giant cells are of either macrophage or myocyte origin.

*This variant carries a poor prognosis.
123. What is the morphology of the myocarditis of Chagas disease?
The myocarditis of Chagas disease is rendered distinctive by parasitization of scattered myofibers by trypanosomes accompanied by an inflammatory infiltrate of neutrophils, lymphocytes, macrophages, and occasional eosinophils.
124. What are the clinical features of myocarditis?
The spectrum of clinical features is broad; at one end the disease is asymptomatic, and at the other extreme is the onset of heart failure or arrhythmias, occasionally w/sudden death.

A systolic murmur may appear, indicating functional mitral regurgitation related to dilation of the left ventricle.

The clinical features of myocarditis can mimic those of acute MI. Occasionally, years later, when an attack of myocarditis is forgotten, the pt may be Dx as having DCM.
125. What type of myocardial disease does doxorubicin cause?
Doxorubicin (Adriamycin) is a well recognized cause of toxic myocardial injury that can cause DCM.

The hazard is dose-dependent and is attributed primarily to lipid peroxidation of myocyte membranes.

Common morphologic threads running throughout the cardiotoxicity of many chemical and drugs (including diphtheria exotoxin) are myofiber swelling and vacuolization, fatty change, individual cell lysis (myocytolysis), and sometimes patchy foci of necrosis.
126. What are the specific electron microscopy findings of Adriamycin cardiotoxicity?
EM usually reveals cytoplasmic vacuolization and lysis of myfibrils, typified by Adriamycin cardiotoxicity.
127. How is cyclophosphamide a toxic myocardial agent?
Cyclophosphamide, like Adriamycin, has dose-dependent cardiotoxic effects, but severe cardiomyopathy may occur following single high-dose therapy.

In contrast to the primary myocyte injury w/Adriamycin, the principal insult w/cyclophosphamide appears to be vascular, leading to myocardial hemorrhage.
128. Can catecholamines cause myocardial injury?
Yes, foci of myocardial necrosis with contraction bands, often associated w/a sparse mononuclear inflammatory infiltrate consisting mostly of macrophages, are freq observed in pts who have a pheochromocytomas.

This is considered to be a manifestation of the general problem of "catecholamine effect", which is also seen in association with the admin of large doses of vasopressor agents such as dopamine.

*The mechanism of damage appears to relate either to direct toxicity of catecholamines to cardiac myocytes via calcium overload or to vasoconstriction in the myocardial circulation in the face of an increased heart rate.
129. What is the morphology of catecholamine induced myocardial injury?
The mononuclear cell infiltrate is likely a secondary reaction to the foci of myocyte cell death.

Similar morphology is found in pts who have recovered from hypotensive episodes or cardiac arrest. In such cases, the damage is a result of ischemia-reperfusion and inflammation follows.
130. What other type of pts also develop focal myocardial necrosis with contraction bands?
Curiously, some pts with intracranial lesions associated with elevated CSF pressure and neurostimulation also develop focal myocardial necrosis with contraction bands.
131. What is senile cardiac amyloidosis (SCA)?
Cardiac amyloid deposits may occur in the ventricles and atria.

***In SCA the protein deposits derive from transthyretin, a normal serum protein that transports both thyroxine and retinol-binding protein.

The cardiac manifestations of isolated SCA may be histologically indistinguishable from those of primary amyloidosis, but SCA can be identified by immunohistochemical staining of tissues with antisera to transthyretin.
132. What is isolated atrial amyloidosis?
*Has a far worse prognosis than SCA.

In this disease, the cardiac involvement is limited to the atria. The deposits consists of atrial natriuretic peptide.
133. What is autosomal dominant familial transthyretin amyloidosis?
This risk of isolated cardiac amyloidosis is 4x greater in African Americans than in Caucasians after age 60.

4% of African Americans have a gene mutation in which isoleucine is substituted for valien at position 122 that produces an amyloidogenic/fibrillogenic form of transthyretin (autosomal dominant familial transthyretin amyloidosis).
134. What are the clinical features of cardiac amyloidosis?
Cardiac amyloidosis most freq produces restrictive hemodynamics, but it can be asymptomatic or can be manifested by dilation, arrhythmias, or features mimicking those of ischemic or valvular disease owing to deposits in the interstitium, conduction system, vasculature, and valves, respectively.
135. What is the morphology of cardiac amyloidosis?
Grossly, the heart varies from normal to firm, rubbery, and noncompliant with thickened walls.

Numerous small, semitranslucent nodules resembling drips of wax may be seen at the atrial endocardial surface, particularly on the left.

***Amyloid deposits are highlighted by the classic apple-green birefringence demonstrated by polarization of tissue selections stained with Congo red or by the sulfated Alcian blue stain.***

In the interstitium, amyloid deposits often form rings around cardiac myocytes and capillaries. This can compress and occlude their lumens, inducing myocardial ischemia.
136. What is iron overload myocardial injury?
Iron overload can occur in either hereditary hemochromatosis or hemosiderosis owing to multiple blood transfusions. The heart is each is usually dilated and the morphology does not belie the cause.

Iron deposition is more prominent in ventricles than atria and in the working myocardium than in the conduction system. It is thought that iron causes systolic dysfunction by interfering w/metal-dependent enzyme systems.
137. What is the morphology of the heart in iron overload?
Grossly, the myocardium is rust-brown in color but is otherwise indistinguishable from that of idiopathic DCM.

***Microscopically, there is marked accumulation of hemosiderin w/in cardiac myocytes, particularly in the perinuclear region, demonstrable with a Prussian blue stain.

This is associated w/varying degrees of cellular degeneration and fibrosis. Ultrastructurally, the cardiac myocytes contain abundant perinuclear siderosomes (iron-containing lysosomes).
138. What are the morphologic cardiac manifestations of hyperthyroidism?
In hyperthryoidism, the gross and histologic features are those of nonspecific hypertrophy.

Cardiac failure occurs uncommonly, usually in the elderly superimposed on other cardiac diseases.
139. What are the morphologic cardiac manifestations of hypothyroidism?

What is a myxedema heart?
Histologic features of hypothyroidism include myofiber swelling with loss of striations and basophilic degeneration, accompanied by interstitial mucopolysaccharide-rich edema fluid.

A similar fluid sometimes accumulates within the pericardial sac. The term myxedema heart has been applied to these changes.
140. What is pericardial effusion?
Under various circumstances, the parietal pericardium undergoes distention by fluid of variable composition. The consequences depend on the ability of the parietal pericardium to stretch, based on the speed of accumulation and the amt of fluid. Thus, with slow accumulations, the only clinical significance is a characteristic globular enlargement of the heart shadow noted on chest x-ray.

In contrast, rapidly developing accumulations may produced compression of the thin-walled atria and venae cavae or the ventricles themselves, leading to cardiac tamponade.
141. What is pericarditis?
Pericardial inflammation is usually secondary to a variety of cardiac diseases. Primary pericarditis is unusual and almost always of viral origin.

Most evoke an acute pericarditis, but a few, such as tuberculosis and fungi, produce chronic reactions.
142. What is serous pericarditis?
Serous inflammatory exudates are characteristically produced by noninfectious inflammations, such as RF, SLE, scleroderma, tumors, and uremia. An infection in the tissues contiguous to the pericardium, for ex, a bacterial pleuritis, may cause sufficient irritation of the pericardial serosa to cause a sterile serous effusion that may progress to serofibrinous pericaditis and ultimately to a frank suppurative reaction.

In some instances, a well defined viral infection elsewhere - URI, pneumonia, parotitis, antedates the pericarditis and serves as the primary focus of infection. Infrequently, usually in young adults, a viral pericarditis occurs as an apparent primary involvement that may accompany myocarditis (myopericarditis).
143. What is the morphology of serous pericarditis?
Whatever the cause, there is an inflammatory reaction in the epicardial and pericardial surfaces w/scant numbers of polymorphonuclear leukocytes, lymphocytes, and macrophages.

Usually the volume of fluid is not large, and it is accumulates slowly.

Dilation and increased permeability of the vessels due to inflammation produces a fluid of high specific gravity and rich protein content.

A mild inflammatory infiltrate in the epipericardial fat consisting predominantly of lymphocytes is frequently termed chronic pericarditis. Organization into fibrous adhesions rarely occurs.
144. What are the most frequent types of pericarditis?
Fibrinous and serofibrinous pericarditis.

THey are composed fo serous fluid mixed with a fibrinous exudate. Common causes include acute MI, the postinfarction (Dressler) syndrome, uremia, chest radiation, RF, SLE, and trauma.

A fibrinous reaction also follows routine cardiac surgery.
145. What is the morphology of fibrinous and serofibrinous pericarditis?
In fibrinous pericarditis, the surface is dry, with a fine granular roughening. In serofibrinous pericarditis, an increased inflammatory process induces more and thicker fluid, which is yellow and cloudy owing to leukocytes and erythrocytes (which may be sufficient to give a visibly bloody appearance), and often fibrin.

As w/all inflammatory exudates, fibrin may be digested with resolution of the exudate or it may become organized.
146. What is the most striking clinical characteristic of fibrinous pericarditis?
The development of a loud pericardial friction rub.

Also, pain, systemic febrile reactions, and signs suggestive of cardiac failure may be present.
147. What is purulent or suppurative pericarditis?
This denotes the invasion of the pericardial space by infective organisms, which may reach the pericardial cavity by several routes.

Immunosuppression predisposes to infection by all routes.

The clinical findings in the acute phase are essentially the same as those present in fibrinous pericarditis, but signs of systemic infection are usually marked: for example, spiking temperatures, chills, and fever.
148. What is the morphology of suppurative pericarditis?
The exudate ranges from a thin to a creamy pus of up to 400-500 mL in volume.

The serosal surfaces are reddened, granular, and coated with an exudate. Microscopically there is an acute inflammatory reaction. Sometimes the inflammatory process extends into surrounding structures to induce a so-called medistinopericarditis.

Organization is the usual outcome; resolution is infrequent.

The organization freq produces constrictive pericarditis.
149. What is hemorrhagic pericarditis?
An exudate composed of blood mixed with a fibrinous or suppurative effusion is most commonly caused by malignant noeplastic involvement of the pericardial space.

Hemorrhagic pericarditis may also be found in bacterial infections, in pts w/an underlying bleeding diathesis, and in tuberuclosis.

It often follows blood loss or even tamponade, required a "second-look" operation.
150. What is caseous pericarditis?
Caseation w/in the pericardial sac is, until proved otherwise, tuberculous in origin; infrequently, fungal infections evoke a similar reaction.

Pericardial involvement occurs by direct spread from tuberculous foci w/in the tracheobronchial nodes.

Caseous pericarditis is rare but is the more freq antecedent of disabling, fibrocalcific, chronic constrictive pericarditis.
151. What is a "soldier's plaque"?

What is adhesive pericarditis?
In some cases, organization merely produces plaque-like fibrous thickening of the serosal membranes ("soldier's plaque") or thin, delicate adhesions of obscure origin that are observed fairly frequently at autopsy and rarely cause impairment of cardiac function.

In other cases, organization results in complete obliteration of the pericardial sac. This fibrosis yields a delicate, stringy type of adhesion between parietal and visceral pericardium called adhesive pericarditis.
152. What is adhesive mediastinopericarditis?
This form of pericardial fibrosis may follow a suppurative or caseous pericarditis, previous cardiac surgery, or irradiation to the mediastinum.

The pericardial sac is obliterated, and adherence of the external aspect of the parietal layer to surrounding structures produces great strain on cardiac function.

Systolic retraction of the rib cage and diaphragm, pulsus paradoxus, and a variety of other characteristic clinical findings may be observed.

***The increased workload causes cardiac hypertrophy and dilation, which may be quite massive in more severe cases, mimicking DCM.***
153. What is constrictive pericarditis?
The heart may be encased in a dense, fibrous, or fibrocalcific scar that limits diastolic expansion and seriously restricts CO, resembling restrictive cardiomyopathy.

The pericardial space is obliterated, and the heart is surrounded by a dense, adherent layer of scar with or without calcification, often 0.5 to 1.0 cm thick, that can resemble a plaster mold in extreme cases (concretio cordis).
154. What is rheumatoid heart disease?
The heart is involved in 20-40% of cases of severe prolonged rheumatoid arthritis.

The most common finding is a fibrinous pericarditis that may progress to fibrous thickening of the visceral and parietal pericardium w/dense fibrous adhesions.

Rheumatoid inflammatory granulomatous nodules resembling those that occur subcutaneously may also be identifiable in the myocardium.

Rheumatoid valvulitis can lead to a marked fibrous thickening and secondary calcification of the aortic valve cusps, producing changes resembling those of chronic rheumatic valvular disease, but intercommisural adhesion is rarely present.
155. What are the most common primary tumors of the heart?
In descending order of frequency:
1. Myxomas
2. Fibromas
3. Lipomas
4. Papillary fibroelastomas
5. Rhabdomyomas
6. Angiosarcomas
7. Other sarcomas
156. What are myxomas?
Myxomas are the most common primary tumor of the heart in adults. Although they may arise in any of the 4 chambers, or the heart valves, about 90% are located in the atria, with a left to right ratio of approx 4:1 (atrial myxomas).

All of the tumors present are thought to derive from differentiation of primitive multipotential mesenchymal cells.
157. What is the morphology of myxomas?

1/2
The tumors are almost always single, but rarely several occur simultaneously. The region of the fossa ovalis in the atrial septum is the favored site of origin.

Myxomas range from small (less than 1 cm) to large (up to 10 cm), sessile or pedunculated masses that vary from globular hard masses mottled with hemorrhage to soft, translucent, papillary, or villous lesions having a gelatinous appearance.
158. What is the morphology of myxomas?

2/2
Histologically, myxomas are composed of stellate or globular myxoma ("lepidic") cells, endothelial cells, smooth muscle cells, and undifferentiated cells embedded w/in an abundant acid mucopolysaccharide ground substance and covered on the surface by endothelium.

Peculiar structures that resemble poorly formed glands or vessels are characteristic. Hemorrhage and mononuclear inflammation are usually present.
159. What are the major clinical manifestations of myxomas?
The major clinical manifestations are due to valvular "ball-valve" obstruction, embolization, or a syndrome of constitutional symptoms, such as fever and malaise.

Sometimes fragmentation with systemic embolization calls attention to these lesions.

Constitutional symptoms are likely due to the elaboration by some myxomas of IL-6.
160. What is Carney syndrome?
Approx 10% of pts with myxoma have a familial cardiac myxoma syndrome known as Carney syndrome.

It is characterized by autosomal dominant transmission, multiple cardiac and often extracardiac (skin) myxomas, spotty pigmentation, and endocrine overactivity.
161. What gene mutations cause Carney syndrome?
The gene PRKAR1 on chromosome 17 (encoding a regulatory subunit of cAMP-dependent protein kinase A, possible a tumor suppressor gene) is mutated in about half of known Carney complex kindreds, while most of the other kindreds have abnormalities in the locus 2p16.
162. What is a cardiac lipoma?
Lipomas are circumscribed but poorly encapsulated, often subendocardial large polypoid accumulations of adipose tissue, more commonly in the left ventricle, right atrium, or septum.

Symptoms depend on location and on encroachment on valve function or conduction pathways. They can created ball-valve obstructions or produce arrhythmias. These are probably hamartomas.
163. What is a papillary fibroelastoma?
Papillary fibroelastomas are curious, usually incidental, lesions, most often identified at autopsy.

They may embolize and become clinically important. Although these masses are called neoplasms, ti is possible that at least some fibroelastomas represent organized thrombi.

Fibroelastomas resemble the much smaller, usually trivial, Lambl excrescences that are freq found on the aortic valves of older individuals.
164. What is the morphology of papillary fibroelastomas?
Papillary fibroelastomas are generally located on valves, particularly the ventricular surfaces of semilunar valves and the atrial surfaces of AV valves.

They constitute a distinctive cluster of hair-like projections up to 1 cm in diameter, covering up to several centimeters in diameter of the endocardial surface.

Histologically, they are covered by endothelium, deep to which is myxoid connective tissue containing abundant mucopolysaccharide matrix and elastic fibers.
165. What are rhabdomyomas?
Rhabdomyomas are the most freq primary tumor of the heart in infants and children and are freq discovered in the first years of life b/c of obstruction of a valvular orifice or cardiac chamber.

Rhabdomyomas are hamartomas or malformations and there is a high freq of tuberous sclerosis in these pts.

*Cardiac rhabdomyomas may be due to a defect in apoptosis during development cardiac remodeling.
166. What is the morphology of rhabdomyomas?
Rhabdomyomas are generally small, gray-white myocardial masses up to several cm in diameter located on either the left or the right side of the heart and protruding into the ventricular chambers.

Histologically they are composed of a mixed population of cells, ***the most characteristic of which are large, rounded, or polygonal cells containing numerous glycogen-laden vacuoles separated by strands of cytoplasm running from the plasma membrane to the more or less centrally located nucleus, the so called "spider cells".*** These cells can be shown to have myofibrils.
167. What are the most freq tumors to involve the heart as metastases?
CAs of the lung and breast, melanomas, leukemias, and lymphomas.

Bronchogenic CA can cause SVC syndrome.

Renal cell CA can cause IVC syndrome.
168. What is acute allograft rejection?
Acute allograft rejection is characterized by interstitial lymphocytic inflammation with associated myocyte damage; severe rejection is accompanied by extensive myocyte necrosis and freq inflammatory vascular injury.
169. What is the major limitation to the long-term success of cardiac transplantation?
The major limitation is late, progressive, diffuse stenosing intimal proliferation of the coronary arteries (graft arteriopathy). This causes downstream myocardial ischemia.

Also, the EBV can cause opportunistic infections and malignancies in immunosuppressed transplant recipients.
170. What is the first step in catecholamine synthesis?
The first step in catecholamine synthesis is the oxidation of tyrosine to dihydroxyphenylalanine (DOPA) by the enzyme tyrosine hydrolase, and is the rate limiting step.
171. How is dopamine created?

How does this lead to norepinephrine?
DOPA is converted to dopamine by a generic aromatic AA decarboxylase.

Dopamine can then be hydroxylated at the 9-position by dopamine-β-hydroxylase to yield norepinephrine.
172. How is epinephrine produced by tissues?
In tissues that produce epinephrine, norepinephrine is then methylated on its amino group by phenylethanolamine-N-methyltransferase (PNMT)
173. How is dopamine transported into synaptic vesicles?
Dopamine is transported into synaptic vesicles by a 12-helix membrane-spanning proton antiporter called the vesicular monamine transporter (VMAT).

Dopamine inside the vesicle is converted to norepinephrine by dopamine-β-hydroxylase.
174. What are hexamethonium and mecamylamine?
Ganglionic blockers such as hexamethonium and mecamylamine block the ganglionic nicotinic ACh receptor, without significant effects on skeletal muscle ACh receptors.
175. What mediates reuptake of catecholamine into the neuronal cytoplasm?
Reuptake of catecholamine into the neuronal cytoplasm is mediated by a selective catecholamine transported (e.g. norepinephrine transporter or NET).

This symporter uses the inward sodium gradient to concentrate catecholamines in the cytoplasm of sympathetic nerve endings, thus limiting the postsynaptic response and allowing neurons to recycle the transmitter for subsequent release.
176. What is MAO and catechol-O-methyltransferase (COMT)?
MAO is a mitochondrial enzyme that is expressed in most neurons. It exists in two isoforms, MAO-A and MAO-B.

The two isoforms have some degree of ligand specificity; MAO-A preferentially degrades serotonin, norepinephrine, and dopamine, while MAO-B degrades dopamine more rapidly than serotonin and norepinephrine.

COMT is a cytosolic enzyme that is expressed primarily in the liver.
177. What are adrenergic receptors?
AKA adrenoceptors; they are selective for norepinephrine and epinephrine.

These receptors are divided into two main classes, termed α & β
178. What is G protein receptor kinase (GRK)?

What is β-arrestin?
The accumulation of the βγ subunits in the membrane recruits a G protein receptor kinase (GRK), which phosphorylates the receptor at residues in the C-terminus that are important targets for inactivator proteins.

The phosphorylated state of a G protein can bind to another protein called β-arrestin that sterically inhibits the receptor-G protein interaction, effectively silencing receptor signaling.
179. What are the epinephrine receptors?
Epinephrine is an agonist at both α & β adrenoceptors.

At low concentrations, epinephrine has predominantly β₁ and β₂ effects, while at high concentrations, its α₁ effects predominate.
180. What are the norepinephrine receptors?
Norepinephrine is an agonist at α₁ and β₁ receptors, but has relatively little effect at β₂ receptors.
181. What are the inhibitors of catecholamine synthesis, and what are they used for?
Inhibitors of catecholamine synthesis have limited clinical utility b/c such agents nonspecifically inhibit the formation of all catecholamines.

α-Methyltyrosine is a structural analogue of tyrosine that is transported into nerve terminals, where it inhibits tyrosine hydroxylase, the first enzyme int he catecholamine biosynthesis pathway.

This agent is used occasionally in the treatment of hypertension associated with pheochromocytoma.
182. α-Methyltyrosine
MOA: Inhibits tyrosine hydroxylase.

PURPOSE: pheochromocytoma associated hypertension

ADVERSE: Orthostatic hypertension and sedation

CONTRA: Hypersensitivity to α-Methyltyrosine

NOTES: *Used rarely.
183. What are inhibitors of catecholamine storage?
MOA: These agents inhibit catecholamine storage in vesicles, resulting short term increase in release of catecholamines from the synaptic terminal ("sympathomimetic") but long-term depletion of available pool of catecholamines ("sympatholytic").

Includes:
1. Reserpine
2. Guanethidine
3. Guanadrel
4. Amphetamine
5. Methylphenidate
6. Pseudoephedrine
184. Reserpine
MOA: Reserpine binds tightly to the vesicular antiporter VMAT. The drug irreversibly damages VMAT, resulting in vesicles that lose their ability to concentrate and store norepinephrine and dopamine.

PURPOSE: Hypertension

ADVERSE: cardiac arrhythmia, GI hemorrhage, thrombocytopenia, dream anxiety disorder, impotence, psychotic depression, dizziness, and nasal congestion.

CONTRA: Active GI disease, depression, electroshock therapy, and renal failure

NOTES: Used experimentally to assess whether effect of drug requires its concentration in presynaptic terminals. Rarely used as a therapeutic agent due to its irreversible action and its association with psychotic depression.
185. Tyramine
Tyramine is a dietary amine that is ordinarily metabolized in the GI tract and liver by MAO. In patients taking MAO inhibitors, tyramine is absorbed in the gut, transported through the blood, and taken up by sympathetic neurosn, where it is transproted into synaptic vesciles by VMAT.

By this mechanism, an acute challenge with large amts of tyramine can cause acute displacement of vesicular NE and massive non-vesicular release of NE from the nerve terminal.
186. Octopamine
Although tyramine itself is poorly retained in synaptic vesicles, its hydroxylated metabolite octopamine can be stored at high concentrations in the vesicles.

B/c octopamine has little agonist activity at most mammalian adrenoceptors, postsynaptic response to sympathetic stimulation may gradually be diminished, leading ultimately to postural hypertension.
187. Guanethidine
MOA: Like tyramine, guanethidine concentrates in transmitter vesicles and displaces NE, leading to gradual depletion of NE.

PURPOSE: Hypertension

ADVERSE: Kidney disease, apnea, orthostatic hypotension, fluid retention, dizziness, blurred vision, impotence.

CONTRA: MAOI therapy, heart failure and pheochromocytoma.

NOTES: Inhibition of cardiac sympathetic nerves leads to reduced cardiac output; inhibition of sympathetic response leads to symptomatic hypotension following exercise.
188. Guanadrel
Guanadrel has similar MOA as guanethidine. Guanadrel also acts as a false neurotransmitter.

As with guanethidine, this agent can be used in the treatment of hypertension, but it is no longer a first line agent.

Adverse effects similar to guanethidine.
189. Amphetamine
MOA: (1) it displaces endogenous catecholamines from storage vesicles; (2) it is a weak inhibitor of MAO; (3) it blocks catecholamine reuptake mediated by NET and DAT.

PURPOSE: ADHD and narcolepsy

ADVERSE: hyperension, tachyarrhythmia, Tourette's syndrome, seizure, psychotic disorder w/prolonged use, restlessness, dysphoric mood, rebound fatigue, addiction potential, loss of appetite, irratibility, erectile dysfunction

CONTRA: advanced cardiovascular disease, glaucoma, hyperthyroidism, MAOI therapy, and severe hypertension.
190. Methylphenidate
Methylphenidate is a structural analogue of amphetamine, and is widely used in psychiatry to treat ADHD in children; its major effect is though to be related to enhanced attention.
191. Pseudoephedrine
MAO: Structurally related agents with actions less marked than those of amphetamine

PURPOSE: Allergic rhinitis and nasal congestion

ADVERSE: atrial fibrillation, ventricular premature beats, myocardial ischemia, hypertension, tachyarrhythmia, rebound congestion, insomnia

CONTRA: advanced cardiovascular disease, MAOI therapy and severe hypertension

NOTES: Used as an OTC decongestant; often found in cold remedies and appetite suppressants. Ephedrine and phenylpropanolamine have been restricted in the US.
192. How do inhibitors of catecholamine reuptake work, and what are they?
These agents inhibit NE transporter (NET) mediated reuptake of catecholamine, potentiating catecholamine action.

In other words, they prolong the time that released neurotransmitter remains in the synaptic cleft.

Includes:
1. Cocaine
2. Imipramine
3. Amitriptyline
193. Cocaine
Cocaine is a potent inhibitor of NET; unlike other uptake inhibitors, cocaine essentially eliminates catecholamine transport.

Cocaine is a controlled substance with high abuse potential. It is used occasionally as a local anesthetic but its most important role is as an agent of abuse.
194. TCAs such as imipramine and amitriptyline
MOA: These agents inhibit NET-mediated reuptake of NE into presynatic terminals, and thus allow accumulation NE in the synaptic cleft. The TCAs also inhibit serotonin as well as NE reuptake into presynaptic terminals and blocking serotonergic, α-adrenergic, histaminergic, and muscarinic receptors at therapeutic doses.

PURPOSE: Depression

ADVERSE: Postural hypotension (through α-adrenergic blockage), sinus tachycardia (through potentiation of NE action on cardiac sympathetic nerves), and arrhythmia

NOTES: Although these drugs begin inhibiting NE and serotonin reuptake immediately, there is a latency period of several weeks before improvement in symptoms is seen.
195. What are MAOIs?
MAOIs prevent secondary deamination following reuptake of catecholamines into presynaptic terminals by inhibiting MAO.

Therefore, more catecholamine accumulates in presynaptic vesicles for release during each action potential.
196. What are the non-selective MAOIs (Agents that inhibit both MAO-A and MAO-B)?
Agents that inhibit both MAO-A and MAO-B:

1. Phenelzine
2. Iproniazid
3. Tranylcypromine
197. What are the selective MAOIs?
Clorgyline is selective for MAO-A

Selegiline is selective for MAO-B
198. What are the newer, reversible inhibitors of MAO-A?
1. Brofaromine
2. Befloxatone
3. Moclobemide
199. Purpose of MAOIs

What about Selegiline?
MAOIs are used to treat depression.

Selegiline is also approved for the treatment of Parkinson's disease; its mechanism fo action may include both potentiation of dopamine in the remaining nigrostriatal neurons and decreased formation of neurotoxic intermediates.
200. MAOI contraindications
Patients taking MAOIs should avoid eating certain fermented food containing large amounts of tyramine and other monoamines, b/c MAOIs block oxidative deamination of these monoamines int eh GI tract and liver, causing a hypertensive crisis.

Concomitant use of MAOIs and SSRIs is also contraindicated b/c it may lead to the serotonin syndrome, characterized by restlessness, tremors, seizures, and possibly coma and death.
201. What are α₁-adrenergic agonists?

What are the names of the α₁-adrenergic agonists?
The α₁-selective adrenergic agonists increase peripheral vascular resistance and thereby maintain or elevate blood pressure.

These drugs may also cause sinus bradycardia through activation of reflex vagal responses.

These include:
1. Methoxamine
2. Phenylephrine
3. Oxymetazoline
4. Tetrahydrazoline
202. Methoxamine
MOA: Selectively activates α₁-adrenergic receptors to increase peripheral vascular resistance

PURPOSE: Hypotension, shock

ADVERSE: Bradycardia (vagal reflex), ventricular ectopic beat, hypertension, vasoconstriction, nausea, headache, and anxiety.

CONTRA: Severe hypertension

NOTES: very limited clinical use in the treatment of shock
203. Phenylephrine, oxymetazoline, and tetrahydrazoline
PURPOSE: Opthalmic hyperemia, nasal congestion, hypotension (phenylephrine only)

ADVERSE: Cardiac arrhythmia, hypertension, headache, insomnia, nervousness, rebound nasal congestion

CONTRA: narrow angle glaucoma, severe hypertension or tachycardia (for IV form of phenylephrine)

NOTES: Used in the OTC remedies Afrin and Visine for relief of nasal congestion and ophthalmic hyperemia; rebound of symptoms often accompanies use of these drugs. Phenylephrine is also used intravenously in the treatment of shock.
204. What are α₂-adrenergic agonists?

What drug is the best characterized α₂-agonist?

What are the names of the α₂-agonists?
MOA: These agents selectively activate central α₂-adrenergic receptors, and thereby inhibit sympathetic outflow from CNS.

**Clonidine is the best characterized α₂-agonist.

Includes:
1. Clonidine
2. Guanabenz
3. Guanfacine
4. Methyldopa
205. Clonidine
MOA: Selectively activates central α₂-adrenergic receptors, and thereby inhibit sympathetic outflow from CNS.

PURPOSE: Hypertension, opioid withdrawal, cancer pain

ADVERSE: Bradycardia, heart failure, hypotension, constipation, xerostomia, sedation, dizziness

NOTES: Clonidine is used for treatment of hypertension and symptoms associated with opioid withdrawal.
206. Guanabenz, guanfacine, and methyldopa
MOA: Selectively activates central α₂-adrenergic receptors, and thereby inhibit sympathetic outflow from CNS.

PURPOSE: Hypertension

ADVERSE: Bradycardia, hepatotoxcity (methyldopa), autoimmune hemolytic anemia (methyldopa), hypotension, constipation, xerostomia, sedation, dizziness.

CONTRA: MAOI therapy and active liver disease (contraindications for use of methyldopa)

NOTES: ***Methyldopa is drug of choice for treatment of hypertension during pregnancy
207. What are β-adrenergic agonists?
Stimulation of β₁-adrenergic receptors causes an increase in heart rate and the force of contraction, resulting in increased cardiac output, while stimulation of β₂-adrenergic receptors causes relaxation of vascular, bronchial, and GI smooth muscle.
208. Isoproterenol
MOA: A nonselective β-agonist; it lowers peripheral vascular resistance and diastolic BP (a β₂ effect), while systolic BP remains unchanged or slightly increased (a β₁ effect). It increases cardiac contractility and cardiac output.

PURPOSE: Bronchoconstriction in asthma, arrhythmia, bradycardia (atropine resistant)

ADVERSE: Stokes-Adams seizures, arrhythmias, cardiac arrest, bronchospasm, hypotension, nervousness, tachycardia, angina, nausea

CONTRA: Angina, cardiovascular disease, hyperthyroidism, DM, tachycardia

NOTES: Causes less hyperglycemia than does epinephrine, because the former agent stimulates β-adrenergic activation of insulin secretion. This drug has been mostly supplanted by newer β₂-selective agonists.
209. Dobutamine isomers
MOA: The (-) isomer acts as both an α₁-agonist and a weak β₁-agonist, whereas the (+) isomer acts as both an α₁-antagonist and a potent β₁-agonist.

The α₁-agonist and α₁-antagonist effectively cancer each other out when the racemic mixture is administered, and the observed clinical result is that of a selective β₁-agonist.
210. What is dobutamine used for?
This agent has more prominent inotropic than chronotropic effects, resulting in increased contractility and cardiac output.

Dobutamine is used clinically in the acute management of heart failure.
211. What are the other β-adrenergic agonists?
Metaproterenol is the prototype β₂ selective agonist. This drug is used to treat obstructive airway disease and acute bronchospasm.

Terbutaline and albuterol are two other agents in this class that have similar efficacy and duration of action.

Salmeterol is a long acting β₂-agonist -its effects last for about 12 hours.
212. What are α-adrenergic antagonists?
α-adrenergic antagonists block endogenous catecholamines from binding to α₁ and α₂ adrenoceptors. These agents cause vasodilation, decreased BP, and decreased peripheral resistance.

The baroreceptor reflex usually attempts to compensate for the fall in BP, resulting in reflex increases in HR and CO.
213. Phenoxybenzamine
MOA: Blocks both α₁ and α₂ receptors irreversibly.

PURPOSE: Pheochromocytoma associated hypertension and sweating

ADVERSE: Seizure, postural hypotension, tachycardia, palpitations, xerostomia, sedation, miosis, absence of ejaculation

CONTRA: Severe hypotension

NOTES: Used only in preoperative management of pheochromocytoma
214. Phentolamine
MOA: Phentolamine is a reversible, nonselective α-adrenoceptor antagonist.

This drug can also be used in the preoperative management of pheochromocytoma.

ADVERSE: same as phenoxybenzamine

CONTRA: Severe hypotension and coronary artery disease
215. Prazosin
MOA: Selective blocker of α₁-receptors in arterioles and veins; results in decreased peripheral vascular resistance and dilation of the venous vessels. Has little tendency to increase cardiac output and HR.

PURPOSE: Hypertension, BPH

ADVERSE: Pancreatitis, hepatotoxicity, SLE, marked first dose hypotension, palpitations, dyspepsia, dizziness, sedation, increased urinary freq, nasal congestion

NOTES: TCAs may increase postural hypotension. Due to potential severe postural hypotension, the dose is generally prescribed for small quantities around bed time.
216. Terazosin and doxazosin
These agents are similar to prazosin but have longer half-life, allowing less frequent dosing.
217. Tamsulosin
MOA: Specific antagonist of α₁ₐ-receptors.

PURPOSE: BPH

ADVERSE: same as prazosin, except less postural hypotension

CONTRA: hypersensitivity to tamsulosin

NOTES: Tamsulin has more specificity for genitourinary smooth muscle, thus it has lower incidence of orthostatic hypotension.
218. Yohimbe
MOA: Selective blockage of α₂-autoreceptors leads to increased release of NE with subsequent stimulation of cardiac β₁-receptors and peripheral vasculature α₁-receptors.

PURPOSE: organic and psychogenic impotence

ADVERSE: Bronchospasm, nervousness, tremor, anxiety, agitation, increased BP, antidiuresis

CONTRA: Chronic inflammation of sexual organs or prostate, concurrent use with mood altering drugs, gastric and duodenal ulcers, pregnancy, psychiatric patients, renal and liver disease.

NOTES: Also leads to increased insulin release due to blockage of α₂-receptors in pancreatic islets.
219. Propanolol, nadolol, and timolol
MOA: Propanolol, nadolol, and timolol interact with β₁ and β₂ receptors equally and do not block α receptors.

PURPOSE: Hypertension, angina, heart failure, pheochromocytoma, glaucoma

ADVERSE: Bronchospasm, AV block, bradyarrhythmia, sedation, decreased libido, mask symptoms of hypoglycemia, depression, dyspnea, wheezing.

CONTRA: Bronchial asthma or COPD, cardiogenic shock, uncompensated cardiac failure, 2nd and 3rd degree AV block, severe sinus bradycardia

NOTES: Propanolol is extremely lipophilic, its concentration is sufficiently high that sedation and decreased libido may result. An ocular formulation of timolol is used for the treatment of glaucoma.
220. Labetalol and carvedilol
MOA: Labetalol and carvedilol block α₁, β₁, and β₂ receptors (labetalol also acts as a weak partial agonist at β₂ receptors but has a 5-10x greater effect as a β blocker). These drugs decrease blood pressure.

PURPOSE: Hypertension and angina

ADVERSE: Same as propanolol, additionally, labetalol can cause hepatotoxicity - liver enzymes must be monitored
221. Pindolol
MOA: Pindolol is a partial agonist at β₁ and β₂ receptors. The drug blocks the action of endogenous norepinephrine at β₁ receptors and is useful in treating hypertension.

As a partial agonist, pindolol also causes partial stimulation of β₁ receptors, leading to overall smaller decreases in resting heart rate and BP than those caused by pure β atagonists.

***Therefore, the drug may be preferable in hypertensive patients who have bradycardia or decreased cardiac reserve.
222. Acebutolol
Acebutolol is a partial agonist at β₁ adrenoceptors but has no effect at β₂ receptors.

This drug is also used to treat hypertension.
223. Esmolol, metoprolol, and atenolol
MOA: Esmolol, metoprolol, and atenolol are β₁-selective adrenergic antagonists. The elimination half life is the main feature that distinguishes these agents. Esmolol has the shortest (3-4 min), metoprolol and antenolol have intermediate (4-9 hrs).

PURPOSE: B/c of its short half-life, esmolol is used for emergency β-blockade as in thyroid storm. Also used in hypertension, angina, and heart failure.
224. Celiprolol
Celiprolol is a β₁-selective antagonist and β₂-selective agonist.

Also used in treating hypertension, angina, and heart failure.